Compare RDY & COKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.
Coca-Cola Consolidated Inc sells nonalcoholic beverage products in the United States. The company purchases concentrate and syrups from other beverage manufacturers under a license, then produces, packages, markets, and distributes the beverages to retailers. The company's primary licensor is Coca-Cola Co., which generally allows it to exclusively market, produce, and distribute Coca-Cola products in specified parts of the U.S.: North Carolina, South Carolina, West Virginia, and parts of Alabama, Georgia, Tennessee, Virginia, Indiana, and Kentucky. The company manages its business in two operating segments. Nonalcoholic Beverages segment which represents the majority of the company's revenues and All Other segments.